NEUCA (WSE:NEU) Might Become A Compounding Machine
Nov 20
Have your own idea? Try our Stock Screener
Polish (WIG) Healthcare Sector Analysis
UpdatedNov 21, 2024
DataAggregated Company Financials
Companies47
- 7D-3.6%
- 3M-8.3%
- 1Y6.7%
- YTD-1.5%
Over the last 7 days, the Healthcare industry has dropped 4.3%, driven by NEUCA declining 5.8%. This takes the industry's 12 month performance to a gain of 6.1%. Earnings are forecast to grow by 23% annually.
Sector Valuation and Performance
Has the Polish Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Thu, 21 Nov 2024 | zł14.6b | zł16.4b | zł52.9m | 20.7x | 275.8x | 0.9x |
| Sat, 19 Oct 2024 | zł15.6b | zł16.4b | zł82.2m | 23.7x | 189.8x | 0.9x |
| Mon, 16 Sep 2024 | zł15.4b | zł16.4b | zł161.0m | 28.6x | 95.9x | 0.9x |
| Wed, 14 Aug 2024 | zł14.9b | zł16.2b | zł132.2m | 31.9x | 112.9x | 0.9x |
| Fri, 12 Jul 2024 | zł15.2b | zł16.2b | zł134.2m | 27.9x | 113.6x | 0.9x |
| Sun, 09 Jun 2024 | zł14.9b | zł16.2b | zł99.9m | 27x | 149x | 0.9x |
| Tue, 07 May 2024 | zł14.8b | zł16.0b | zł85.9m | 38.3x | 172.7x | 0.9x |
| Thu, 04 Apr 2024 | zł14.8b | zł15.4b | -zł125,052,549.00 | 39.4x | -118.1x | 1x |
| Sat, 02 Mar 2024 | zł15.1b | zł16.0b | -zł199,514,549.00 | 40.7x | -75.5x | 0.9x |
| Mon, 29 Jan 2024 | zł14.9b | zł15.9b | -zł247,198,884.00 | 34.5x | -60.4x | 0.9x |
| Wed, 27 Dec 2023 | zł15.0b | zł15.9b | -zł245,263,080.00 | 30.9x | -61.2x | 0.9x |
| Fri, 24 Nov 2023 | zł13.7b | zł15.9b | zł144.7m | 29.9x | 94.9x | 0.9x |
| Sun, 22 Oct 2023 | zł13.8b | zł15.7b | zł114.5m | 31.1x | 120.5x | 0.9x |
| Tue, 19 Sep 2023 | zł14.1b | zł15.7b | zł80.6m | 18.4x | 174.8x | 0.9x |
| Thu, 17 Aug 2023 | zł14.3b | zł15.4b | zł109.2m | 20.2x | 131.3x | 0.9x |
| Sat, 15 Jul 2023 | zł14.7b | zł15.4b | zł101.1m | 27x | 145.4x | 1x |
| Mon, 12 Jun 2023 | zł14.2b | zł15.5b | zł186.6m | 24.7x | 76x | 0.9x |
| Wed, 10 May 2023 | zł13.9b | zł15.3b | zł201.2m | 27.1x | 69.3x | 0.9x |
| Fri, 07 Apr 2023 | zł13.0b | zł15.4b | zł248.1m | 26.3x | 52.2x | 0.8x |
| Sun, 05 Mar 2023 | zł13.9b | zł15.1b | zł259.2m | 28.7x | 53.6x | 0.9x |
| Tue, 31 Jan 2023 | zł13.4b | zł15.0b | zł237.9m | 26.8x | 56.2x | 0.9x |
| Thu, 29 Dec 2022 | zł12.4b | zł15.0b | zł227.4m | 24.1x | 54.6x | 0.8x |
| Sat, 26 Nov 2022 | zł12.4b | zł15.1b | -zł136,064,130.00 | 21.9x | -90.9x | 0.8x |
| Mon, 24 Oct 2022 | zł11.4b | zł14.8b | -zł130,100,544.00 | 22.8x | -87.6x | 0.8x |
| Wed, 21 Sep 2022 | zł12.0b | zł15.0b | zł248.3m | 20x | 48.2x | 0.8x |
| Fri, 19 Aug 2022 | zł13.1b | zł14.7b | zł275.5m | 22.3x | 47.7x | 0.9x |
| Sun, 17 Jul 2022 | zł12.3b | zł14.8b | zł265.8m | 19x | 46.1x | 0.8x |
| Tue, 14 Jun 2022 | zł11.8b | zł14.8b | zł267.5m | 17.5x | 44.3x | 0.8x |
| Thu, 12 May 2022 | zł13.1b | zł14.9b | zł849.5m | 28.1x | 15.4x | 0.9x |
| Sat, 09 Apr 2022 | zł14.7b | zł14.9b | zł908.2m | 23.6x | 16.2x | 1x |
| Mon, 07 Mar 2022 | zł13.9b | zł14.8b | zł906.6m | 19.9x | 15.3x | 0.9x |
| Wed, 02 Feb 2022 | zł15.9b | zł14.9b | zł936.2m | 24x | 17x | 1.1x |
| Fri, 31 Dec 2021 | zł17.2b | zł14.8b | zł930.4m | 25.8x | 18.5x | 1.2x |
| Sun, 28 Nov 2021 | zł17.4b | zł14.8b | zł949.6m | 24.5x | 18.3x | 1.2x |
Price to Earnings Ratio
18.3x
Current Industry PE
- Investors are optimistic on the Polish Healthcare industry, and appear confident in long term growth rates.
- The industry is trading at a PE ratio of 273x which is higher than its 3-year average PE of 49.8x.
- The industry is trading close to its 3-year average PS ratio of 0.93x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have declined 62% per year over the last three years.
- Meanwhile revenues for these companies have grown 3.5% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.
Industry Trends
Which industries have driven the changes within the Polish Healthcare sector?
| PL Market | -3.15% | |
| Healthcare | -3.64% | |
| Pharma | 3.76% | |
| Healthtech | -1.21% | |
| Healthcare Services | -4.11% | |
| Biotech | -4.12% | |
| Medical Equipment | -6.05% | |
| Life Sciences | -7.36% | |
Industry PE
- Investors are most optimistic about the Healthcare Services industry even though it's trading below its 3-year average PE ratio of 27.7x.
- Analysts are expecting annual earnings growth of 18.7%, which is lower than the prior year's growth of 53.0% per year.
Forecasted Growth
- Analysts are most optimistic on the Pharma industry, expecting annual earnings growth of 67% over the next 5 years.
- This is better than its past earnings growth rate of 29% per year.
- In contrast, the Biotech industry is expected to see its earnings grow by 2.5% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| CLN Celon Pharma | zł27.45 | 3.0% +zł43.1m | 87.0% | PS7.1x | |
| MOC Molecure | zł11.30 | 17.7% +zł28.6m | -33.8% | PS125x | |
| RDG Read-Gene | zł5.24 | 6.9% +zł4.0m | 51.4% | PS5.3x | |
| SVE Synthaverse | zł4.42 | 1.1% +zł3.5m | -9.5% | PE125.5x | |
| BSN BrainScan Sp. z o. o | zł33.00 | 10.0% +zł3.5m | n/a | n/a |